Login to Your Account



From 2 to 29 Offerings in 4 Years

Popularity of ATMs Continues To Grow, Record High in Q3

By Brian Orelli
BioWorld Insight Contributing Writer

Monday, December 17, 2012

As biotech executives look to get off the treadmill of financing their companies from milestone to milestone, at-the-market (ATM) offerings have become more popular. According to Brinson Patrick Securities Corp., use of ATM offerings by life sciences companies reached a record high in the third quarter.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription